Argus Research analyst Jasper Hellweg maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) yesterday. The company’s shares ...

Wedge Capital Management L L P NC decreased its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 26.0% ...

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

Representative Josh Gottheimer (D-New Jersey) recently sold shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed ...

Financial writer cautious on Eli Lilly stock despite strong performance, citing high valuation and underperforming drugs.

INDIANAPOLIS - Eli Lilly and Company (NYSE:LLY) revealed positive outcomes from two phase 3 clinical trials, QWINT-1 and QWINT-3, for its once-weekly insulin efsitora alfa... Eli Lilly and Company ...

Antiobesity drugs are amazing people by how fast they melt off pounds. But it's no surprise to Richard DiMarchi.

NEW YORK, Jan. 9, 2025 /PRNewswire/ -- Thrive Global announced today it is working with Eli Lilly and Company to embed behavior change tools and resources onto LillyDirect and into traditional ...

Humalog + Insulin Lispro have maintained a dominant ... in this case calculated on the basis of the last 12 months. Eli Lilly is an outstanding company, but the market may have overestimated ...